Rodrigo España

Inspiring change in the area of neurophysiology and addiction research, Rodrigo España, PhD, is a distinguished professor at Drexel University's College of Medicine, within the Department of Neurobiology & Anatomy. His pioneering research delves into the neural underpinnings of motivated behavior and the intricate dynamics of substance addiction. Dr. España's work is particularly focused on the roles of neurochemical systems such as hypocretin/orexin, dopamine, and norepinephrine, and their influence on sleep/arousal, reward, and reinforcement processes. Dr. España employs a variety of advanced methodologies, including electrophysiology, voltammetry, and optogenetics, to explore how these neurochemical systems regulate behaviors associated with addiction. His research aims to unravel the complexities of addiction-related behaviors and to pave the way for the development of innovative treatments for substance use disorders. By understanding the neural circuits and mechanisms that contribute to addiction, Dr. España's work holds promise for improving relapse prevention strategies. Collaboration is a cornerstone of Dr. España's research approach. He actively collaborates with esteemed colleagues at Drexel University, the University of Pennsylvania, and Hager Biosciences. These partnerships enhance the breadth and depth of his research, allowing for a multidisciplinary approach to understanding and addressing the challenges of addiction. Dr. España's contributions to the field of neuroscience extend beyond his research. He is dedicated to mentoring the next generation of scientists, fostering an environment of curiosity and innovation. His commitment to education and research excellence has made him a respected figure in the academic community. Through his groundbreaking work, Dr. Rodrigo España continues to inspire change and advance the understanding of the neural mechanisms underlying addiction. His efforts are instrumental in shaping future interventions and therapies that can effectively address the global challenge of substance use disorders.